SME Central
Home / SME Stocks / Remus Pharmaceuticals

Remus Pharmaceuticals: IPO, Share Price and Results Since Listing

Remus Pharmaceuticals listed on NSE Emerge on 29 May 2023 after an IPO at INR 1,229 a share. On 11 November 2026 the shares closed at INR 798.90, 35% below the issue price. For H1 FY2027 it reported revenue of INR 614.12 crore (+53.45% on a year earlier) and a profit after tax of INR 24.66 crore.

Key Facts

IPO dates
17 May 2023 to 19 May 2023
Issue price
INR 1,229
Issue size
INR 47.69 crore
Subscription
56.59 times
Lead manager
Beeline Capital Advisors Private Limited
Listing day
opened at INR 1,711.25 (+39.24%), closed at INR 1,796.80 (+46.20%)
Listed on NSE Emerge
29 May 2023
Symbol
REMUS
Latest close
INR 798.90 on 11 November 2026
Against issue price
-35%
Lot size now
100 shares (INR 79,890 at the latest close)

Results Filed With NSE

Consolidated figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
H1 FY2027614.12+53.45%24.6620.92after listing3 November 2026
H2 FY2026453.43+30.39%24.5820.86after listing20 May 2026
FY2026853.63+37.60%46.1739.19after listing20 May 2026
H1 FY2026400.20โ€“21.5918.33after listing10 November 2025
H2 FY2025347.75โ€“20.5734.92after listing19 May 2025
FY2025620.36โ€“38.4265.21after listing19 May 2025

Promoter Holding

Promoter holding has moved from 68.37% on 24 May 2023 to 70.95% on 30 September 2026 (+2.58 percentage points).

As ofPromotersPublic
30 September 202670.95%29.05%
31 March 202670.95%29.05%
30 September 202570.91%29.09%
7 July 202570.85%29.15%
31 March 202570.85%29.15%
30 September 202470.84%29.16%
10 June 202470.66%29.34%
31 March 202470.60%29.40%
30 September 202369.61%30.39%
24 May 202368.37%31.63%

Anchor Lock-ins

Lock-inEnds
30 days23 June 2023
90 days22 August 2023

Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.